Sonova Holding (OTCMKTS:SONVY) Given Average Rating of “Hold” by Analysts

Shares of Sonova Holding (OTCMKTS:SONVYGet Free Report) have received an average rating of “Hold” from the eight brokerages that are currently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company.

Several brokerages have recently weighed in on SONVY. BNP Paribas Exane upgraded shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research report on Tuesday, March 10th. Citigroup restated a “sell” rating on shares of Sonova in a research report on Wednesday, May 13th. Zacks Research upgraded shares of Sonova from a “strong sell” rating to a “hold” rating in a research report on Monday, February 9th. Finally, Jefferies Financial Group downgraded shares of Sonova from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, March 18th.

Read Our Latest Stock Report on SONVY

Sonova Stock Performance

Shares of Sonova stock opened at $51.92 on Wednesday. Sonova has a 52-week low of $42.26 and a 52-week high of $63.69. The company has a 50 day moving average of $46.75 and a 200 day moving average of $49.90. The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51.

Sonova Company Profile

(Get Free Report)

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

Recommended Stories

Analyst Recommendations for Sonova (OTCMKTS:SONVY)

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.